Insulin-induced gene as therapeutic target in diabetes

Details for Australian Patent Application No. 2004230565 (hide)

Owner Merck Patent GmbH Centre National De La Recherche Scientifique (C.N.R.S)

Inventors Coffy, Sandrine; Asfari, Maryam

Agent Davies Collison Cave

Pub. Number AU-A-2004230565

PCT Pub. Number WO2004/092411

Priority 03/04835 17.04.03 FR

Filing date 18 March 2004

Wipo publication date 28 October 2004

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/092411 Priority application(s): WO2004/092411

15 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230567-Antimicrobial pigments

2004230562-Liquid active substance dispenser for W.C. bowl